title: Ganglioside GD3 enhances apoptosis by suppressing the nuclear factor-kappa B-dependent survival pathway.
authors: Liver Unit, Instituto de Malalties Digestives, Hospital Clinic i Provincial, Barcelona, 08036, Spain.
authors: A
authors: A
authors: Colell
authors: C
authors: C
authors: García-Ruiz
authors: J
authors: J
authors: Roman
authors: A
authors: A
authors: Ballesta
authors: J C
authors: JC
authors: Fernández-Checa
mesh_terms: D021581:Active Transport, Cell Nucleus / Q000187:drug effects; D000818:Animals; D017209:Apoptosis; D002478:Cells, Cultured; D005732:Gangliosides / Q000494:pharmacology*; D015870:Gene Expression / Q000187:drug effects; D022781:Hepatocytes / Q000166:cytology / Q000187:drug effects* / Q000378:metabolism; D016328:NF-kappa B / Q000037:antagonists & inhibitors / Q000378:metabolism*; D051381:Rats
chemical_list: D005732:Gangliosides; D016328:NF-kappa B; C026226:ganglioside, GD3